BioSpace News Archive

Innovate UK funded project supports development of scalable, cost effective production of regenerative medicines

System is Fully Integrated with Medtronic’s Market-Leading Imaging and Navigation Technology to Transform Posterior Cervical Spine Surgery

Ground-breaking technology unlocks rapid and simple label-free 3D and 4D live cell imaging

Blue Cross and Blue Shield of Georgia is taking an innovative approach to helping its consumers who have been diagnosed with Type 2 diabetes manage their condition to improve their health through a new virtual diabetes clinic with a smartphone app and monitoring tools.

There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.

Motif Bio plc today announced unaudited financial results for the half year ended June 30, 2018 and reported on its progress year to date.

Quanticate, has announced that it has partnered with CluePoints™ to utilize their software to drive the statistical analysis to perform data integrity checks on all types of monitoring and investigator site data as part of its new Data Quality Oversight service that enables centralized statistical monitoring, in response to the amendments to the ICH Good Clinical Practice (GCP) E6(R2) guidelines.

Statistically Significant Improvement in Kidney Function Observed in Both Diseases After 12 Weeks of Treatment

Eli Lilly just signed a license deal with Tokyo’s Chugai Pharmaceutical Co. for OWL833, Chugai’s oral non-peptidic GLP-1 receptor agonist. It is Phase 1-ready being evaluated for type 2 diabetes.

McAllen, Texas, Ranked Most Challenging City for Fall Allergies